Regenxbio (RGNX) Enterprise Value (2015 - 2026)
Regenxbio (RGNX) reported Enterprise Value of $543.37 million for Q2 2026, up 501.1% from $90.4 million a year earlier and up 92.2% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Enterprise Value (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regenxbio's Enterprise Value came in at -$111.4 million; for FY2025, it was $502.77 million, up 239.0% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of -16.3% (FY2020 to FY2025).
- By year, Enterprise Value came in at $148.33 million in FY2024 (-71.2%), $515.37 million in FY2023 (-16.5%), $617.38 million in FY2022 (-34.5%) and $943.13 million in FY2021 (-23.0%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value since Q1 2024.
- Year over year, Enterprise Value has now increased in each of the last three quarters, with growth averaging 83.7% over the last eight quarters.
- The high point for year-over-year Enterprise Value in five years was Q2 2026 (growth of 501.1%); the low point was Q1 2025 (a decline of 87.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $282.74 million (Q1 2026), $502.77 million (Q4 2025) and $214.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Regenxbio | 418.33 Mn | -341.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 543.37 Mn |
| Dec 31, 2025 | 502.77 Mn |
| Sep 30, 2025 | 214.27 Mn |
| Jun 30, 2025 | 90.40 Mn |
| Mar 31, 2025 | 90.47 Mn |
| Dec 31, 2024 | 148.33 Mn |
| Sep 30, 2024 | 264.15 Mn |
| Jun 30, 2024 | 286.65 Mn |
| Mar 31, 2024 | 694.63 Mn |
| Dec 31, 2023 | 515.37 Mn |
| Sep 30, 2023 | 422.20 Mn |
| Jun 30, 2023 | 551.90 Mn |
| Mar 31, 2023 | 490.11 Mn |
| Dec 31, 2022 | 617.38 Mn |
| Sep 30, 2022 | 761.79 Mn |
| Jun 30, 2022 | 663.36 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 943.13 Mn |
| Sep 30, 2021 | 1.45 Bn |
| Jun 30, 2021 | 1.28 Bn |
API Access
Regenxbio Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();